The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

The main goals of chronic obstructive pulmonary disease (COPD) management include treatment of symptoms and prevention of exacerbations. Current guidelines recommend use of one or more long-acting ...

The trick is finding the right treatment plan for you. “COPD can come in a few different varieties. Some people have just emphysema, some have just chronic bronchitis, and a lot of people have l ...

Treatment can often successfully manage symptoms of COPD, but it’s a serious condition. Current treatments for COPD cannot repair the damage to your lungs, but some treatments may reduce your ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

It's the first ever biologic medicine for COPD in either country. Specifically, the drug is indicated in both countries as an add-on treatment for patients with inadequately controlled COPD and an ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

Dr Sundeep Salvi: Shardul Nautiyal, Mumbai Tuesday, March 4, 2025, 08:00 Hrs [IST] Chronic obstructive pulmonary disease (C ...